Brief verbal intervention to address inappropriate prescriptions of chinese patent medicines among western practitioners in primary health care (BRAVERY): a study protocol for an unannounced standardized patient experiment with a factorial design randomized controlled trial in China
Zhao Q, Lin L, Kwan A, Hu H, Wu L, Chen Y, Shi Z, Li B, Xiao J, Tong G, He W, Luo H, Li Q, Wang R, Zhong D, Liu S, Xie Y, Li J, Zhang L, Huang Z, Zhu X, Wan Y, Chen X, Huang W, Tian Y, Li X, Zhou Y, Cai Y, Xu D. Brief verbal intervention to address inappropriate prescriptions of chinese patent medicines among western practitioners in primary health care (BRAVERY): a study protocol for an unannounced standardized patient experiment with a factorial design randomized controlled trial in China. BMC Complementary Medicine And Therapies 2025, 25: 150. PMID: 40269893, PMCID: PMC12020188, DOI: 10.1186/s12906-025-04870-6.Peer-Reviewed Original ResearchConceptsUnannounced standardized patientsRandomized Controlled TrialsPrimary healthcareGeneralized linear mixed modelsWestern medicine practitionersPrimary health careControlled TrialsFactorial design randomized controlled trialStudy protocolDesign randomized controlled trialChinese patent medicineVerbal interventionsChina Clinical Trial RegistryPatent medicineClinical Trials RegistryPrimary outcome evaluationStandardized patientsHealth careLinear mixed modelsMedical encountersControl providersTargeted policy interventionsIntervention researchPatient expectationsAppropriateness of antibiotic prescriptions
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply